Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 18, 2019 02:00 ET | Source: Arvelle Therapeutics

Risultati di uno studio randomizzato che valuta la sicurezza e l'efficacia del cenobamate nei pazienti con epilessia focale non controllata pubblicato su The Lancet Neurology

ZUG, Svizzera, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Arvelle Therapeutics GmbH, una società biofarmaceutica emergente focalizzata su trattamenti innovativi per pazienti con disturbi del sistema nervoso...
November 15, 2019 02:00 ET | Source: Arvelle Therapeutics

Arvelle to Present at Jefferies 2019 London Healthcare Conference

Arvelle to Present at Jefferies 2019 London Healthcare Conference Zug, Switzerland, November 15, 2019 - Arvelle Therapeutics GmbH (“Arvelle”), an emerging biopharmaceutical company focused on...
November 14, 2019 02:00 ET | Source: Arvelle Therapeutics

Results of Randomized Study Evaluating the Safety and Efficacy of Cenobamate in Patients with Uncontrolled Focal-Onset Epilepsy Published in The Lancet Neurology

ZUG, Switzerland, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Arvelle Therapeutics GmbH, an emerging biopharmaceutical company focused on bringing innovative treatments to patients with CNS disorders, today...
October 31, 2019 02:00 ET | Source: Arvelle Therapeutics

Arvelle Therapeutics Strengthens Management Team with Key New Hires

Arvelle Therapeutics Strengthens Management Team with Key New Hires Appoints Petra Molan as Senior Vice President Commercial and Enrico Dolfini as...